Daily as of 3 Nov 16:00 ET
- Price
- between the two $11.95 vs 50 $13.56 / 200 $10.91
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 22 Aug 2025 · projected 19 bars out
FDMT | 4D Molecular TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$11.95
+$0.58 (+5.10%)
4D Molecular Therapeutics (FDMT) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2022.
The 50 SMA has sat above the 200 on the daily since Aug 2025, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the weekly, price sits between the 50 and the 200; on the 4-hour it is below both.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- between the two $11.90 vs 50 $10.52 / 200 $13.18
- Projection
- No cross projected
- Test
- No active test
- Last cross
- No cross on record
4-hour as of 3 Nov 13:30 ET
- Price
- below both $11.95 vs 50 $12.61 / 200 $12.57
- Projection
- 💀Death cross projected in 1 bar
- Test
- No active test
- Last cross
- 🟨Golden cross 25 Jun 2026 · projected 11 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 25 Jun 2026 | 🟨Golden | 4-hour | 11 bars out | Not tested |
| 15 Jun 2026 | 💀Death | 4-hour | 12 bars out | 5 bar cross test |
| 13 Apr 2026 | 🟨Golden | 4-hour | 22 bars out | Not tested |
| 12 Jan 2026 | 💀Death | 4-hour | 27 bars out | 3 bar cross test |
| 22 Aug 2025 | 🟨Golden moderate | daily | 19 bars out | Not tested |
About FDMT
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$11.8M
4-hour coverageYes, since Oct 2025
History on recordSince 2022
SectorHealthcare
Cap bandsmall